Mr Diego Penela

Mr Diego Penela

Medical Centre Teknon, Grupo Quironsalud, Barcelona (Spain)

2012: Specialty in Cardiology (MIR). Hospital Clínic de Barcelona 2017: PhD, Universidad de Barcelona. 2012-2015: Specialist in Electrophysiology, Arrhythmia Section, Cardiology Department, Hospital Clinic de Barcelona. 2019: Specialist in Electrophysiology, Heart Institute, Teknon Medical Center

Presentations Articles

Cardioneuroablation for vasovagal syncope. Results from an EHRA Survey

Event: EHRA 2024

Topic: Treatment

Session: Syncope

Access

CTA in Left Atrium Management: Wall Thickness to PV Isolation and Cardioneuroablation

Event: EHRA 2024

Topic: Techniques and Technology

Session: CTA in Left Atrium Management: Wall Thickness to PV Isolation and Cardioneuroablation

Access

Personalized Pulmonary Vein Isolation with Very High-Power Short-Duration Lesions guided by Left Atrial Wall Thickness: the QDOT-by-LAWT Randomized Trial

Event: EHRA 2024

Topic: Rhythm Control, Catheter Ablation

Session: Late-Breaking Science: ablation

Access

Outcomes of ventricular tachycardia substrate ablation facilitated by preprocedural imaging scar characterization. A prospective multicenter registry

Event: EHRA 2023

Topic: Ablation of Ventricular Arrhythmias

Session: Ventricular Arrhythmias and SCD - Round 3 - Ablation

Access

Ventricular tachycardia substrate ablation in patients with slightly depressed left ventricular ejection fraction. Predictors of VT-free survival in a prospective multicentre registry

Event: EHRA 2023

Topic: Epidemiology, Prognosis, Outcome

Session: ePoster session 8

Access

A Left sided site of origin is associated with adverse cardiovascular outcomes in patients with LV dysfunction undergoing PVC ablation

Event: EHRA 2021

Topic: Epidemiology, Prognosis, Outcome

Session: New insights in ventricular arrhythmias I

Access

How to predict the site of origin - Increasing efficiency by using all the available tools

Event: EHRA 2019

Topic: Treatment

Session: Premature ventricular complex ablation in patients with heart failure - What have we learned?

Access

Mortality and morbidity reduction after frequent PVC ablation in patients with LV systolic dysfunction

Event: EHRA 2019

Topic: Ablation of Ventricular Arrhythmias

Session: Rapid Fire 2: new topics in ablation of ventricular arrhythmias

Access

Predictors of ablation success: any role of the surface ECG?

Event: EHRA 2018

Topic: Ventricular Arrhythmias and SCD - Treatment

Session: Ablation of premature ventricular contractions

Access

Complications during ablation of ventricular arrhythmias

Event: EHRA 2018

Topic: Arrhythmias, General – Treatment

Session: Complications during ablation/device implantation: the role of the nurse/allied professional

Access

ESC 365 is supported by

Explore sponsored resources

Mr Diego Penela

Biography

Contributor content

Cardioneuroablation for vasovagal syncope. Results from an EHRA Survey

CTA in Left Atrium Management: Wall Thickness to PV Isolation and Cardioneuroablation

Personalized Pulmonary Vein Isolation with Very High-Power Short-Duration Lesions guided by Left Atrial Wall Thickness: the QDOT-by-LAWT Randomized Trial

Outcomes of ventricular tachycardia substrate ablation facilitated by preprocedural imaging scar characterization. A prospective multicenter registry

Ventricular tachycardia substrate ablation in patients with slightly depressed left ventricular ejection fraction. Predictors of VT-free survival in a prospective multicentre registry

A Left sided site of origin is associated with adverse cardiovascular outcomes in patients with LV dysfunction undergoing PVC ablation

How to predict the site of origin - Increasing efficiency by using all the available tools

Mortality and morbidity reduction after frequent PVC ablation in patients with LV systolic dysfunction

Predictors of ablation success: any role of the surface ECG?

Complications during ablation of ventricular arrhythmias

ESC 365 is supported by

Mr Diego Penela Follow

Biography

Contributor content

Cardioneuroablation for vasovagal syncope. Results from an EHRA Survey

CTA in Left Atrium Management: Wall Thickness to PV Isolation and Cardioneuroablation

Personalized Pulmonary Vein Isolation with Very High-Power Short-Duration Lesions guided by Left Atrial Wall Thickness: the QDOT-by-LAWT Randomized Trial

Outcomes of ventricular tachycardia substrate ablation facilitated by preprocedural imaging scar characterization. A prospective multicenter registry

Ventricular tachycardia substrate ablation in patients with slightly depressed left ventricular ejection fraction. Predictors of VT-free survival in a prospective multicentre registry

A Left sided site of origin is associated with adverse cardiovascular outcomes in patients with LV dysfunction undergoing PVC ablation

How to predict the site of origin - Increasing efficiency by using all the available tools

Mortality and morbidity reduction after frequent PVC ablation in patients with LV systolic dysfunction

Predictors of ablation success: any role of the surface ECG?

Complications during ablation of ventricular arrhythmias

ESC 365 is supported by

Mr Diego Penela